These final results, together with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 assistance the thought of targeting ACKR3 as a novel way to modulate the opioid technique, which could open up new therapeutic avenues for opioid-related Problems.Be aware: Success may well range abo